Skip to main content
. 2021 Nov 1;4(11):e2129647. doi: 10.1001/jamanetworkopen.2021.29647

Figure 2. Variation in the Use of Moderately Hypofractionated Radiation Therapy (HRT) Over Time for Intermediate-Risk Prostate Cancer.

Figure 2.

CRT indicates conventional radiation therapy; NSW/ACT, New South Wales and Australian Capital Territory; and SA/NT, South Australia and Northern Territory.